Skandinaviska Enskilda Banken (SEB)’s BioTelemetry, Inc. BEAT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-64,371	Closed	-$4.64M	–	1249
2020 Q4	$4.64M	Buy	64,371 +18,512	+40%	+$969K	0.03%	394
2020 Q3	$2.09M	Buy	45,859 +15,901	+53%	+$665K	0.02%	558
2020 Q2	$1.35M	Buy	29,958 +2,148	+8%	+$96.2K	0.01%	661
2020 Q1	$1.07M	Buy	+27,810	New	+$1.28M	0.01%	636
2019 Q3	–	Sell	-10,707	Closed	-$516K	–	954
2019 Q2	$516K	Buy	+10,707	New	+$563K	﹤0.01%	731

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s BEAT Position: Q1 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 64,371 shares — an estimated $4.64M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in BEAT in Q2 2019 and held it in 5 quarters. The position peaked at $4.64M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Skandinaviska Enskilda Banken (SEB) reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 64,371 BioTelemetry, Inc. shares in Q1 2021, an estimated $4.64M.
Skandinaviska Enskilda Banken (SEB) first reported a position in BioTelemetry, Inc. in Q2 2019 and held it in 5 quarters.
Skandinaviska Enskilda Banken (SEB)'s BioTelemetry, Inc. position peaked at $4.64M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2021, filed 14 May 2021.